
SNYR Stock Forecast & Price Target
SNYR Analyst Ratings
Bulls say
Synergy CHC is well-positioned to capitalize on the large and growing brain health supplements and energy RTD industries, with its strong and expanding FOCUSfactor product line and new focus plus energy RTD. Despite recent weaker results, the company has a solid financial performance and is making progress across its strategic priorities, with strong potential for near term catalysts to drive the stock price. The stock is currently undervalued due to concerns, but we believe the potential for growth and profitability presents high rewards for investors.
Bears say
Synergy CHC is facing weak financial performance with a decline in revenue and earnings in Q1 2026, despite strong performance in its beverages segment. The recent termination of a significant distribution deal and out-of-stock issues for key online items raise concerns about the company's ability to meet its goals. There are also significant potential risks such as balance sheet and liquidity concerns, changes in consumer demand, and competition that could impact the company's overall stock performance in the health and wellness industry.
This aggregate rating is based on analysts' research of Synergy CHC Corp and is not a guaranteed prediction by Public.com or investment advice.
SNYR Analyst Forecast & Price Prediction
Start investing in SNYR
Order type
Buy in
Order amount
Est. shares
0 shares